In brief
Australia's TGA has announced reforms targeting sunscreen testing standards, ingredient quality, and SPF labeling, after a public consultation that highlighted consumer confidence gaps. Scientists, industry, and consumer groups weighed in on the proposals, which aim to reduce skin‑cancer risk in a country with the highest incidence worldwide.
Australia’s Therapeutic Goods Administration (TGA) yesterday unveiled a set of reforms aimed at bolstering sunscreen regulation, a step prompted by reports that some products fail to meet their labelled sun‑protective factor (SPF) in independent testing.
The proposals were released amidst a backdrop of rising skin‑cancer rates—the country boasts the world’s highest incidence—which the TGA said is a key motivator for ensuring that sunscreens marketed to the public truly perform as advertised.
Reform Overview
The core of the reform package involves tightening requirements for sunscreen testing, setting stricter quality thresholds for specific active ingredients, and limiting the range of SPF claims cosmetic sunscreens may make. The TGA will also review its existing good manufacturing practice guidance to clarify what is expected of manufacturers and to support continued confidence in product quality and performance.
According to a TGA statement, the agency will consult again on SPF labeling before any final changes are adopted, signalling an intent to keep the rules flexible and responsive to new scientific data.
Stakeholder Responses
Between March and May, the TGA opened a public consultation period that drew almost 120 responses from a diverse array of stakeholders. Participants included representatives from testing laboratories, health professionals, consumer advocacy groups, academic researchers and industry bodies. All groups engaged the agency’s proposals with varying perspectives.
Industry voices largely welcomed the call for clearer testing guidelines, arguing the modifications would level the playing field and prevent unsubstantiated claims from undermining genuine products. Yet some manufacturers cautioned that stricter testing might introduce operational burdens and longer lead times for product approvals.
Consumer groups, meanwhile, lauded the move as a necessary step to protect shoppers from deceptive labeling. They noted that the public’s trust in sun‑protection products had been eroded by recent studies revealing discrepancies between advertised and actual SPF values.
Scientific support for the reforms came strongly from Dr. David Whiteman, a leading researcher at QIMR Berghofer Medical Research Institute. He explained that the proposed changes would enhance the rigor and transparency of sunscreen testing, helping to close the gap between industry claims and real‑world performance.
Dr. Whiteman highlighted that “some sunscreens in independent tests failed to meet their labelled SPF, which has shaken public confidence.” He added that the reforms are critical for maintaining the credibility of the regulatory system and for ultimately reducing the burden of skin cancer in the population.
Next Steps
The TGA has indicated that further consultation on SPF labeling will be conducted before final policy is established. The agency’s statements emphasise a commitment to “review good manufacturing practice guidance to clarify expectations and responsibilities” as part of a broader push to safeguard consumer confidence.
As the process unfolds, stakeholders will need to monitor how the new rules are implemented and whether they achieve the intended effect of reducing mislabeling and improving product efficacy. The outcomes will have implications for manufacturers, retailers, health professionals, and, most importantly, everyday Australians who rely on sunscreen to protect themselves from harmful ultraviolet radiation.
This regulatory shift marks a significant moment in the country’s public health strategy, underscoring the civic importance of governing consumer products that have a direct impact on population health.
